Efficacy of sulfadoxine-pyrimethamine and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon basin of Peru

Alan J. Magill; Jorge Zegarra; Coralith Garcia; Wilmer Marquiño; Trenton K. Ruebush

doi:10.1590/S0037-86822004000300015

Efficacy of sulfadoxine-pyrimethamine and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon basin of Peru

Alan J. Magill
, Jorge Zegarra
, Coralith Garcia
, Wilmer Marquiño
, Trenton K. Ruebush

NAMRID-Unit 3800
Walter Reed Army Institute of Research
Mental Honorio Delgado-Hideyo Noguchi
Centers for Disease Control and Prevention

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

In vivo antimalarial drug efficacy studies of uncomplicated Plasmodiumfalciparum malaria at an isolated site in the Amazon basin of Peru bordering Brazil and Colombia showed >50% RII/RIII resistance to sulfadoxine-pyrimethamine but no evidence of resistance to mefloquine.

Original language	English
Pages (from-to)	279-281
Number of pages	3
Journal	Revista da Sociedade Brasileira de Medicina Tropical
Volume	37
Issue number	3
DOIs	https://doi.org/10.1590/S0037-86822004000300015
State	Published - 2004
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Antimalarial drug resistance
Mefloquine
Peru
Plasmodium falciparum
Sulfadoxine- pyrimethamine

Access to Document

10.1590/S0037-86822004000300015

Cite this

@article{f6eef5c62b224b6b946387ef9b09694f,

title = "Efficacy of sulfadoxine-pyrimethamine and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon basin of Peru",

abstract = "In vivo antimalarial drug efficacy studies of uncomplicated Plasmodiumfalciparum malaria at an isolated site in the Amazon basin of Peru bordering Brazil and Colombia showed >50\% RII/RIII resistance to sulfadoxine-pyrimethamine but no evidence of resistance to mefloquine.",

keywords = "Antimalarial drug resistance, Mefloquine, Peru, Plasmodium falciparum, Sulfadoxine- pyrimethamine",

author = "Magill, \{Alan J.\} and Jorge Zegarra and Coralith Garcia and Wilmer Marqui{\~n}o and Ruebush, \{Trenton K.\}",

year = "2004",

doi = "10.1590/S0037-86822004000300015",

language = "Ingl{\'e}s",

volume = "37",

pages = "279--281",

journal = "Revista da Sociedade Brasileira de Medicina Tropical",

issn = "0037-8682",

number = "3",

}

TY - JOUR

T1 - Efficacy of sulfadoxine-pyrimethamine and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon basin of Peru

AU - Magill, Alan J.

AU - Zegarra, Jorge

AU - Garcia, Coralith

AU - Marquiño, Wilmer

AU - Ruebush, Trenton K.

PY - 2004

Y1 - 2004

N2 - In vivo antimalarial drug efficacy studies of uncomplicated Plasmodiumfalciparum malaria at an isolated site in the Amazon basin of Peru bordering Brazil and Colombia showed >50% RII/RIII resistance to sulfadoxine-pyrimethamine but no evidence of resistance to mefloquine.

AB - In vivo antimalarial drug efficacy studies of uncomplicated Plasmodiumfalciparum malaria at an isolated site in the Amazon basin of Peru bordering Brazil and Colombia showed >50% RII/RIII resistance to sulfadoxine-pyrimethamine but no evidence of resistance to mefloquine.

KW - Antimalarial drug resistance

KW - Mefloquine

KW - Peru

KW - Plasmodium falciparum

KW - Sulfadoxine- pyrimethamine

UR - https://www.scopus.com/pages/publications/2942719077

U2 - 10.1590/S0037-86822004000300015

DO - 10.1590/S0037-86822004000300015

M3 - Artículo

C2 - 15330070

AN - SCOPUS:2942719077

SN - 0037-8682

VL - 37

SP - 279

EP - 281

JO - Revista da Sociedade Brasileira de Medicina Tropical

JF - Revista da Sociedade Brasileira de Medicina Tropical

IS - 3

ER -

Efficacy of sulfadoxine-pyrimethamine and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon basin of Peru

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this